(Q35842279)

English

Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis

scientific article published in April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

0 references

8

object named as

Julio S G Montaner

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

12

object named as

Janet Raboud

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

7

object named as

Nima Machouf

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2

object named as

Mona R Loutfy

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

9

object named as

Sean Rourke

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Curtis L Cooper

5

object named as

Curtis Cooper

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

6

object named as

Marina Klein

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

CANOC Collaboration

13

object named as

CANOC Collaboration

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Richard Harrigan

4

object named as

P Richard Harrigan

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Christos Tsoukas

10

object named as

Christos Tsoukas

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

J Troy Grennan

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

DeSheng Su

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Bob Hogg

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

1 April 2012

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

205

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1230-1238

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

27 July 2018

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

27 July 2018

Update on HIV-1 viral load blips

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

27 July 2018

Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

27 July 2018

Viral Blip Dynamics during Highly Active Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

27 July 2018

Prevalence and predictive value of intermittent viremia with combination hiv therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

27 July 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

27 July 2018

Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

No evidence of an association between transient HIV viremia ("Blips") and lower adherence to the antiretroviral medication regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Toward HIV eradication or remission: the tasks ahead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308904

24 September 2018

Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS104

21 January 2018

Cohort Profile: The Canadian Observational Cohort collaboration

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS104

21 January 2018

Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS104

21 January 2018

Transient Viremia in HIV-Infected Patients and Use of Plasma Preparation Tubes

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS104

21 January 2018

Analyzing Plasma HIV-1 RNA Measurements as Multiple Recurrent Events in Clinical Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22438396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22438396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22438396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22438396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22438396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22438396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIS104

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35842279&oldid=1743579434"